Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • india

    Tag: India

    You Searched For "india"
    Sun Pharma, Rockwell Medical ink licensing pact for Triferic in India

    Sun Pharma, Rockwell Medical ink licensing pact for Triferic in India

    MD bureau16 Jan 2020 10:30 AM IST
    As per the terms of the agreement, Sun Pharma will be the exclusive development and commercialisation partner for Triferic during the term of the...
    CDSCO, Saudi Food and Drug Authority ink agreement for medical products regulations

    CDSCO, Saudi Food and Drug Authority ink agreement for medical products regulations

    Medical Dialogues Bureau3 Nov 2019 10:24 AM IST
    An MoU was signed between the Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare and Saudi Food and Drug...
    Mylan moves application with DCGI to launch new TB drug Pretomanid in India

    Mylan moves application with DCGI to launch new TB drug Pretomanid in India

    Medical Dialogues Bureau16 Oct 2019 4:10 PM IST
    "We have submitted the new drug application to the office of DCGI. We are in an advanced stage of discussion and are working with the office of...
    PIL against Health Ministry notifying 8 medical devices as DRUGS, Delhi HC seeks Centre reply

    PIL against Health Ministry notifying 8 medical devices as DRUGS, Delhi HC seeks Centre reply

    Medical Dialogues Bureau30 Sept 2019 5:54 PM IST
    It was submitted that notifying blood monitoring devices, digital thermometers, nebulizers and glucometers as DRUGS will result in a substantial hike...
    Biocon Chief Kiran Shaw, FM Nirmala Sitharaman in tiff over E-Cigarette ban

    Biocon Chief Kiran Shaw, FM Nirmala Sitharaman in tiff over E-Cigarette ban

    Farhat Nasim20 Sept 2019 5:01 PM IST
    New Delhi: Biocon Chief Kiran Mazumdar Shaw recently got into a spat with the Finance Minister Nirmala Sitharaman on Thursday. The minister defended...
    GSK Consumer Healthcare net profit rises by 24 percent to Rs 248 crore in Q1

    GSK Consumer Healthcare net profit rises by 24 percent to Rs 248 crore in Q1

    Farhat Nasim2 Aug 2019 9:15 AM IST
    The company had posted a net profit of Rs 200.44 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Consumer Healthcare said...
    SAARC nations favour India-based Haslab for Homoeopathic Medicines

    SAARC nations favour India-based Haslab for Homoeopathic Medicines

    Medical Dialogues Bureau6 July 2019 9:45 AM IST
    Haslab as they are known in the homoeopathy market, they provide various forms of homoeopathic products like eye drops, homoeopathic complex tablets,...
    Centre ask States not to partner with Philip Morris-led anti-smoking group

    Centre ask States not to partner with Philip Morris-led anti-smoking group

    Medical Dialogues Bureau2 July 2019 9:15 AM IST
    India's federal health ministry has sent a letter, dated June 24, to chief secretaries of all states, saying they should not partner with FSFW and...
    Drug marketers as liable as Drug Manufacturers for quality, efficacy, regulatory compliance: Health Ministry Issues Draft

    Drug marketers as liable as Drug Manufacturers for quality, efficacy, regulatory compliance: Health Ministry Issues Draft

    Farhat Nasim28 Jun 2019 4:44 PM IST
    New Delhi: Through a recent draft Gazette notification, the Ministry of Health and Family Welfare has informed that not just drugmakers but drug...
    GSK to fund doctoral programs at Government established Regional Centre for Biotechnology

    GSK to fund doctoral programs at Government established Regional Centre for Biotechnology

    Medical Dialogues Bureau27 Jun 2019 9:30 AM IST
    Under this initiative, the RCB will develop program content, manage logistics and oversee the running of the full-time programs while GSK...
    GSK Pharma to optimise product portfolio to drive growth in India

    GSK Pharma to optimise product portfolio to drive growth in India

    Medical Dialogues Bureau24 Jun 2019 9:19 AM IST
    GSK is also looking to launch some new products in the country over the next 15 months as it adopts a more structured approach to engage trade channel...
    Novartis India appoints Sanjay Murdeshwar as Vice Chairman, Managing Director

    Novartis India appoints Sanjay Murdeshwar as Vice Chairman, Managing Director

    Farhat Nasim16 Jun 2019 9:31 AM IST
    Sanjay Murdeshwar is Country President, Novartis in India and responsible for the company's pharmaceuticals business in the country.New Delhi: Pharma...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok